News News Select Year All Years 2026 (24) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 496 Results Page 46 of 50« First«...102030...4445464748...»Last » September 4, 2013 DBV Technologies initiates a long-term follow-up study of Viaskin Peanut July 8, 2013 DBV Technologies completes enrollment of Phase IIb VIPES study, the first-ever global trial in desensitization to peanut allergy June 28, 2013 DBV Technologies announces breakthrough Data Presentations at EAACI-WAO Congress June 20, 2013 Viaskin Peanut demonstrates strong efficacy trend in severely peanut-allergic children in 18-month results of ARACHILD pilot study June 4, 2013 DBV Technologies’ June 4th, 2013 Combined Shareholders’s Meeting May 16, 2013 Stallergenes and DBV Technologies enter into partnership for the development of innovative treatment of respiratory allergies May 7, 2013 DBV Technologies and Mount Sinai Hospital enter into a Research Collaboration Agreement April 25, 2013 DBV Technologies publishes its 2012 Registration Document and its 2012 Annual Financial Report April 14, 2013 DBV Technologies’ first quarter 2013 Topline and cash position March 5, 2013 DBV Technologies enters into a strategic manufacturing agreement with Sanofi Page 46 of 50« First«...102030...4445464748...»Last »
